Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Sponsor
Power Life Sciences Inc.
Study ID
NCT05535283
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Osteosarcoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about osteosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with osteosarcoma who are invited to take part in medical research will benefit from the analysis of the data.

Key Dates

First listed
Sep 10, 2022
Start date
Oct 31, 2024
Status verified
Dec 2023
Primary completion
Oct 31, 2025
Completion
Oct 31, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of patients who decide to enroll in an osteosarcoma clinical trial [ Time Frame: 3 months ]

Central Contacts

Related Studies